Goldbeck L, Baving A, Kohne E
Universitäts-Kinderklinik Ulm.
Klin Padiatr. 2000 Sep-Oct;212(5):254-9. doi: 10.1055/s-2000-9683.
Longtime outcome in case of thalassemia depends on the patients' adherence in home treatment to reduce hemosiderosis. This study describes the patients' perspective, their typical coping strategies, health related locus-of-control-beliefs and psychosocial influences on adherence.
A battery of questionnaires was employed to 43 patients with thalassemia major (3 to 26 years old) treated in Germany according to the german multicenter study respectively their parents: the Ulm Thalassemia Inventory, the KIDCOPE, the Multidimensional Health Locus of Control Scales and the Giessen Complaint List. Clinical symptoms of hemosiderosis were correlated with psychosocial variables.
The patients feel more distressed from their treatment than from their illness itself. They react to disease-related distress with a variety of coping strategies. Some of the most frequent coping strategies are maladaptive, indicating feelings of helplessness. Internal locus-of-control-beliefs were low and fatalistic locus-of-control-beliefs were high compared with other clinical groups. The self-reported adherence to the iron chelation treatment is correlated with age, gender, age at the start-point of the treatment and emotional distress. Complaints, coping strategies and locus of control are independent from adherence as well as from hemosiderosis.
Patients with thalassemia major need more information about their disease and about the benefits of iron chelation therapy. Additional psychosocial support should reduce emotional distress, strengthen coping competence and lead to a better integration of therapy in daily life.
地中海贫血患者的长期预后取决于其在家中治疗时对减少铁过载的依从性。本研究描述了患者的观点、他们典型的应对策略、与健康相关的控制点信念以及影响依从性的社会心理因素。
根据德国多中心研究,分别对43例在德国接受治疗的重型地中海贫血患者(3至26岁)及其父母进行了一系列问卷调查:乌尔姆地中海贫血量表、儿童应对量表、多维健康控制点量表和吉森症状清单。铁过载的临床症状与社会心理变量相关。
患者对治疗的苦恼多于对疾病本身的苦恼。他们用各种应对策略来应对与疾病相关的苦恼。一些最常见的应对策略是适应不良的,表明存在无助感。与其他临床组相比,内控信念较低,宿命论控制点信念较高。自我报告的铁螯合治疗依从性与年龄、性别、治疗起始年龄和情绪困扰相关。症状、应对策略和控制点与依从性以及铁过载无关。
重型地中海贫血患者需要更多关于其疾病以及铁螯合治疗益处的信息。额外的社会心理支持应减少情绪困扰,增强应对能力,并使治疗更好地融入日常生活。